Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The ideal cancer therapy not only induces the death of all localized tumor cells without damage to surrounding normal tissue, but also activates a systemic antitumor immunity. High intensity focused ultrasound (HIFU) has the potential to be such a treatment, as it can non-invasively ablate a targeted tumor below the skin surface, and may subsequently augment host antitumor immunity. This chapter is to introduce the history and principles of HIFU tumor ablation, and its biological effects on the tumor microenvironment. It will review increasing pre-clinical and clinical evidence suggesting that HIFU ablation may enhance host antitumor immunity, and discuss its potential mechanisms and roles in terms of local recurrence and metastasis control after HIFU treatment.

More information Original publication

DOI

10.1007/978-94-007-4694-7_4

Type

Chapter

Publication Date

2013-01-01T00:00:00+00:00

Pages

61 - 75

Total pages

14